Hepion Pharmaceuticals HEPA

Hepion Pharmaceuticals increases stock shares

Form
8-K
Filed
Importance
Routine
  1. Filed Certificate of Amendment on Oct 1, 2026
  2. Authorized shares increased to 750,000,000
  3. Effective upon filing with Delaware Secretary of State

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Get an email when Hepion Pharmaceuticals files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.